Human binding molecules having killing activity against staphylococci and uses thereof

Details for Australian Patent Application No. 2007255384 (hide)

Owner Crucell Holland B.V.

Inventors Throsby, Mark; De Kruif, Cornelis Adriaan; Geuijen, Cecilia A.W.

Agent Davies Collison Cave

Pub. Number AU-B-2007255384

PCT Pub. Number WO2007/141274

Priority 07103584.4 06.03.07 EP; 60/811,477 06.06.06 US; 06124231.9 16.11.06 EP

Filing date 5 June 2007

Wipo publication date 13 December 2007

Acceptance publication date 27 September 2012

International Classifications

C07K 16/12 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 39/40 Medicinal preparations containing antigens or antibodies - bacterial

A61P 31/04 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/141274 Priority application(s): WO2007/141274

27 September 2012 Application Accepted

  Published as AU-B-2007255384

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007255388-Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

2007255381-Composites of inorganic and/or organic microparticles and nano-dolomite particles